StocksBausch Health Companies IncBHC

BHC

Bausch Health Companies Inc

6.33 0.07 (1.12%)
Prezzi ritardati da NASDAQ, in USD Mercato chiuso
Investi
S
6.33
B
6.36
Top
Biochemist6641
" $BHC (Bausch Health Companies Inc) lost 1.5 billion in value mainly on an analyst report that the patent case allowed for generic entry in 2025. When in reality the decision prohibited Norwich from entering until 2029 or earlier if Supreme Court overturns TEVA vs GSK" - Jacob S. Sherkow Professor... Mostra di più Traduci
Biochemist6641
$BHC (Bausch Health Companies Inc) has a #LanyaVirus treatment - Ribavirin is a well-known first line treatment strategy for suspected viral infections of unknown etiology. Ribavirin exhibits antiviral activity against a wide variety of both RNA and some DNA viruses (Sidwell et al., 1972) pubmed.ncbi.nlm.nih.gov/4340949/... Mostra di più Traduci
MarketUpdates
Modificato
Il rapporto sugli utili di $BHC (Bausch Health Companies Inc) riferiti al T3 2022 dovrebbe essere pubblicato
8
NOV
REPORT
Il rapporto sugli utili riferiti al Bausch Health Companies Inc T3 2022 dovrebbe essere pubblicato a mercati chiusi
Avvisami
BHC
BHC
Bausch Health Companies Inc
6.33
0.07
(1.12%)
Investi
BHC
Bausch Health Companies Inc
6.33
0.07 (1.12%)
Investi
MarketUpdates
Modificato
$BHC (Bausch Health Companies Inc) Q3 2022 earnings report is expected to be released Traduci
BHC
Bausch Health Companies Inc
6.33
0.07 (1.12%)
Investi
Teodor Nica
❞ Panelists are now expressing concern about a softening in the economy, as new order rates contracted for the second month amid developing anxiety about excess inventory in the supply chain 🔺 Central banks need to hike rates until demand destruction stops inflation. That involves a temporary economic... Mostra di più Traduci